Breast Implant Safety & Certification: CE, MDR and FDA Explained

Which Approval Applies to Implants Sold in Turkey?

Short answer: CE marking under the European Medical Device Regulation (MDR 2017/745). In Turkey, medical devices are regulated by the Turkish Medicines and Medical Devices Agency (TİTCK), and Turkey's Medical Device Regulation is harmonised with EU MDR 2017/745. Every breast implant legally sold in Turkey must carry the CE mark and be registered in the national Product Tracking System (ÜTS).

The FDA (U.S. Food and Drug Administration) is the regulatory authority of the United States market. FDA approval is required to sell a product in the USA — it is neither required nor applicable for sales in Turkey or Europe. Manufacturers based in Europe and focused on the European market naturally follow the CE/MDR pathway; this is not a shortcoming but a consequence of the target market.

MDR 2017/745: The World's Most Recent Device Regulation

The European Medical Device Regulation (MDR 2017/745) came fully into force on 26 May 2021, replacing the previous directive (MDD 93/42/EEC). MDR is among the most current and comprehensive regulatory frameworks in the medical device sector and mandates:

• Strengthened clinical evidence: Requirements were significantly increased for high-risk devices (breast implants are Class III).
• Continuous post-market surveillance (PMS): Manufacturers must continuously collect and report safety data while the product is on the market.
• Unique Device Identification (UDI): Every implant is individually traceable — patient, lot and serial number.
• EUDAMED registration: Transparent registration in the central European device database.
• Independent Notified Body oversight: Certification is granted and regularly audited by accredited bodies independent of the manufacturer.

GC Aesthetics® pioneered this transition: Luna XT™ is the first breast implant on the market certified under the new MDR. This is independently verified proof that GCA products meet the requirements of the world's most current device-safety framework.

What "Not FDA Approved" Means — and What It Doesn't

• Absence of FDA approval does not mean absence of safety. Not applying to the FDA is usually a commercial decision: if a manufacturer does not plan to sell in the US market, it does not apply to the US regulator. European manufacturers certify within the European framework.
• CE/MDR is not a "weaker" standard than the FDA. Post-2021 MDR is among the strictest frameworks globally in terms of clinical evidence and post-market surveillance. Breast implants are assessed in MDR's highest risk class (Class III) and subject to its most demanding requirements.
• The right questions when deciding in Turkey: "Is this implant CE marked, registered in ÜTS, and does the manufacturer have clinical data and a warranty?" For GC Aesthetics® products, the answer to all three is yes.

Our 10 years of published clinical follow-up, studies extended to 17 years, and the lifetime GCA Comfort Plus™ Warranty are concrete commitments showing that safety is more than an approval on paper.

GC Aesthetics® Safety Commitments

• CE certification and MDR 2017/745 compliance — audited by an independent Notified Body
• Luna XT™: the first breast implant certified under the new MDR
• More than 3 million implants worldwide in the past decade
• 10 years of published clinical data + follow-up studies extended to 17 years
• Lifetime GCA Comfort Plus™ Warranty — free replacement for rupture and capsular contracture
• Individual traceability: every implant registered by lot and serial number, ÜTS and UDI compliant
• 72-hour response commitment for warranty and safety reports

For questions contact us or explore our implant size guide.